MORAGA, Calif., Oct. 09, 2017 -- MacKenzie Capital Management, LP and Lemon Creek Advisers, LP have announced a tender offer for Class A Shares (the “Shares”) Pendrell Corporation (NASDAQ:PCO). The Purchasers are offering to purchase up to 1,000,000 Shares of Class A stock for $1.00 per Share.
Shareholders should read the Offer to Purchase and the related materials carefully because they contain important information. Shareholders may obtain a free copy of the Tender Offer Statement on Schedule TO, the Offer to Purchase, the Letter to Shareholders, the Assignment Form, and other documents that the company has filed with the U.S. Securities and Exchange Commission at the commission’s website at www.sec.gov. Shareholders also may obtain a copy of these documents, without charge, from our website at www.mackenziecapital.com (click on Tenders), or by calling toll free at 800-854-8357. If you wish to tender your Shares, and your Shares are held in your brokerage account, you need to instruct your broker to tender your Shares.
Contact: Christine Simpson, 800-854-8357 x. 1024
MacKenzie Capital Management, LP
1640 School Street
Moraga, California 94556


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



